Biotech Stocks Hitting the Public Market This Year: Best Ones to Watch
Last year was a record year for biotech stocks, with an impressive number of companies going public and raising a significant amount of money in the space. In fact, in 2018 there were 80 biotech ... [Read]
ABIO Stock Gets Attention: Are You Watching ARCA Biopharma?
ABIO stock has been on fire over the past two trading sessions, with a huge jump of 150%. As far as biopharmaceutical companies are concerned, positive news of some variety can often send the stock ... [Read]
ARQL Stock Doubles in 2 Months: What to Do with ArQule Now?
ARQL stock is on fire this year, and much of those gains are due to ArQule Inc’s (NASDAQ:ARQL) handsome cash balance and developments that bode well for its flagship drug, ARQ 531. The Burlington, Massachusetts-based ... [Read]
ADMA Stock Receives Consensus “Buy” Rating, Major Upswing Ahead?
ADMA stock has just received a consensus rating of “Buy” from nine brokerages covering the stock. With all in agreement, why are analysts bullish on this biotechnology stock? Let’s find out! AMDA Stock Selling for ... [Read]
AXSM Stock Climbs 550%: Key Drivers Investors Should Be Looking For
Little known biopharmaceutical AXSM stock has been on a tear, and the stock has jumped by a staggering 550% as big news regarding one of the Axsome Therapeutics Inc’s (NASDAQ:AXSM) drugs proved decisive for many ... [Read]
IPATF Stock Soars: Subsidiary Receives Exclusive License from Stanford
On Friday, April 26, ImmunoPrecise Antibodies’ subsidiary U-Protein Express disclosed that it’s obtained an exclusive license from Stanford University. The license allows U-Protein Express to manufacture and sell Wnt surrogate Fc. On the news, IPATF ... [Read]
ImmunoPrecise Antibodies’ Subsidiary U-Protein Express Announces Exclusive Agreement as Global Supplier for Wnt-Surrogate-Fc Growth Factor
VICTORIA, April 25, 2019 /CNW/ – ImmunoPrecise Antibodies Ltd.(TSX:IPA)(OTC:IPATF)(FRA: TQB2)(the “Company” or “IPA”) U-Protein Express, a wholly-owned ImmunoPrecise Antibodies subsidiary, in Utrech, Netherlands, announced that it has obtained an exclusive license from Stanford University to ... [Read]
AKTX Stock Flying after Announcing Positive Phase 2 Clinical Trial Data
Akari Therapeutics (NASDAQ:AKTX) is making headlines after the biopharmaceutical company announced positive data from a Phase 2 clinical trial. The news, released today, sent AKTX stock up nearly 20% at the time of writing. AKTX ... [Read]
Undervalued Penny Stocks Right Now? Two Potential Plays
On the hunt for penny stocks? April has delivered us some significant climbers and now that we are over halfway through the month, looking ahead at what will happen come May is important. In this ... [Read]
MBRX Stock Up 150% on Moleculin Lung Cancer Discovery
Moleculin Biotech (NASDAQ:MBRX) has got investors on the edge of their seats. On Monday, April 22, the company said it made a “significant discovery” for lung cancer and will be discussing it on a conference ... [Read]